SAM
HRMY icon

Smartleaf Asset Management’s Harmony Biosciences HRMY Stock Holding History

Smartleaf Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13K Hold
32
– – ﹤0.01% 3082
2026
Q1 		$861 Sell
32
-269
-89% -$8.82K ﹤0.01% 3143
2025
Q4 		$11.3K Hold
301
– – ﹤0.01% 2340
2025
Q3 		$8.32K Buy
301
+7
+2% +$241 ﹤0.01% 2188
2025
Q2 		$9.4K Sell
294
-259
-47% -$8.33K ﹤0.01% 1842
2025
Q1 		$18.4K Sell
553
-24
-4% -$860 ﹤0.01% 1648
2024
Q4 		$19.7K Buy
577
+330
+134% +$11.3K ﹤0.01% 1653
2024
Q3 		$9.66K Buy
247
+173
+234% +$6.08K ﹤0.01% 1776
2024
Q2 		$2.33K Buy
74
+60
+429% +$1.8K ﹤0.01% 2171
2024
Q1 		$469 Buy
+14
New +$449 ﹤0.01% 1749

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Smartleaf Asset Management's HRMY Position: Q2 2026 in Review

Smartleaf Asset Management held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 32 shares worth $1.13K. The position accounts for ﹤0.01% of the portfolio, ranked #3082.

Smartleaf Asset Management first reported a position in HRMY in Q1 2024 and has held it in 10 quarters since. The position peaked at $19.7K in Q4 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Smartleaf Asset Management held 32 shares of Harmony Biosciences worth $1.13K as of Q2 2026.
  • Smartleaf Asset Management left its Harmony Biosciences share count unchanged in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #3082 holding.
  • Smartleaf Asset Management first reported a position in Harmony Biosciences in Q1 2024 and has held it in 10 quarters since.
  • Smartleaf Asset Management's Harmony Biosciences position peaked at $19.7K in Q4 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.